London Daily

Focus on the big picture.
Saturday, May 31, 2025

Not only blood clots? EMA ‘assessing reports’ of AstraZeneca jab link to rare IMMUNE DISORDER

Not only blood clots? EMA ‘assessing reports’ of AstraZeneca jab link to rare IMMUNE DISORDER

The European Medicines Agency (EMA) is investigating reports of AstraZeneca’s Covid-19 vaccine causing Guillain-Barre syndrome, as the pharmaceutical company remains embroiled in controversy over the jab’s link to blood clotting.
In a meeting this week, the European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) revealed that it was “assessing reports” of the rare immune system disorder being found in people following vaccination.

“As part of the review of the regular pandemic summary safety reports for Vaxzevria, AstraZeneca’s Covid-19 vaccine, the PRAC is analysing data provided by the marketing authorization holder on cases of Guillain-Barre syndrome (GBS) reported following vaccination”, the PRAC declared.

“GBS was identified during the marketing authorization process as a possible adverse event requiring specific safety monitoring activities”, the committee continued, adding that it has requested “further detailed data” on the cases and will release new information as it becomes available.

According to the UK’s National Health Service (NHS), Guillain-Barre syndrome is a “very rare and serious condition that affects the nerves”, and can create feelings of numbness, weakness, and pain in those who have it.

Though the NHS advises that Guillain-Barre syndrome is a treatable condition and that “most people will eventually make a full recovery”, it can also be life-threatening and leave those who have had it with “long-term problems”

Following hundreds of cases of blood clotting – and dozens of deaths – AstraZeneca’s Covid-19 vaccine has already been restricted in many countries to older people only.

In the UK, those under the age of 40 are set to be offered an alternative vaccine provided this causes no “delays” in the vaccination program, however the European Medicines Agency maintains that the vaccine’s benefits outweigh the risk for much of the population.
Newsletter

Related Articles

0:00
0:00
Close
Satirical Sketch Sparks Political Spouse Feud in South Korea
Indonesia Quarry Collapse Leaves Multiple Dead and Missing
South Korean Election Video Pulled Amid Misogyny Outcry
Asian Economies Shift Away from US Dollar Amid Trade Tensions
Netflix Investigates Allegations of On-Set Mistreatment in K-Drama Production
US Defence Chief Reaffirms Strong Ties with Singapore Amid Regional Tensions
Vietnam Faces Strategic Dilemma Over China's Mekong River Projects
Malaysia's First AI Preacher Sparks Debate on Islamic Principles
White House Press Secretary Criticizes Harvard Funding, Advocates for Vocational Training
France to Implement Nationwide Smoking Ban in Outdoor Spaces Frequented by Children
Meta and Anduril Collaborate on AI-Driven Military Augmented Reality Systems
Russia's Fossil Fuel Revenues Approach €900 Billion Since Ukraine Invasion
U.S. Justice Department Reduces American Bar Association's Role in Judicial Nominations
U.S. Department of Energy Unveils 'Doudna' Supercomputer to Advance AI Research
U.S. SEC Dismisses Lawsuit Against Binance Amid Regulatory Shift
Alcohol Industry Faces Increased Scrutiny Amid Health Concerns
Italy Faces Population Decline Amid Youth Emigration
U.S. Goods Imports Plunge Nearly 20% Amid Tariff Disruptions
OpenAI Faces Competition from Cheaper AI Rivals
Foreign Tax Provision in U.S. Budget Bill Alarms Investors
Trump Accuses China of Violating Trade Agreement
Gerry Adams Wins Libel Case Against BBC
Russia Accuses Serbia of Supplying Arms to Ukraine
EU Central Bank Pushes to Replace US Dollar with Euro as World’s Main Currency
Chinese Woman Dies After Being Forced to Visit Bank Despite Critical Illness
President Trump Grants Full Pardons to Reality TV Stars Todd and Julie Chrisley
Texas Enacts App Store Accountability Act Mandating Age Verification
U.S. Health Secretary Ends Select COVID-19 Vaccine Recommendations
Vatican Calls for Sustainable Tourism in 2025 Message
Trump Warns Putin Is 'Playing with Fire' Amid Escalating Ukraine Conflict
India and Pakistan Engage Trump-Linked Lobbyists to Influence U.S. Policy
U.S. Halts New Student Visa Interviews Amid Enhanced Security Measures
Trump Administration Cancels $100 Million in Federal Contracts with Harvard
SpaceX Starship Test Flight Ends in Failure, Mars Mission Timeline Uncertain
King Charles Affirms Canadian Sovereignty Amid U.S. Statehood Pressure
Trump Threatens 25% Tariff on iPhones Amid Dispute with Apple CEO
Putin's Helicopter Reportedly Targeted by Ukrainian Drones
Liverpool Car Ramming Incident Leaves Multiple Injured
Australia Faces Immigration Debate Following Labor Party Victory
Iranian Revolutionary Guard Founder Warns Against Trusting Regime in Nuclear Talks
Macron Dismisses Viral Video of Wife's Gesture as Playful Banter
Cleveland Clinic Study Questions Effectiveness of Recent Flu Vaccine
Netanyahu Accuses Starmer of Siding with Hamas
Junior Doctors Threaten Strike Over 4% Pay Offer
Labour MPs Urge Chancellor to Tax Wealthy Over Cutting Welfare
Publication of UK Child Poverty Strategy Delayed Until Autumn
France Detains UK Fishing Vessel Amid Post-Brexit Tensions
Calls Grow to Resume Syrian Asylum Claims in UK
Nigel Farage Pledges to Reinstate Winter Fuel Payments
Boris and Carrie Johnson Welcome Daughter Poppy
×